Sunesis announces pricing of $20 million offering of securities
Sunesis Pharmaceuticals announced the pricing of underwritten public offerings of 23,000,000 shares of its common stock and 17,000 shares of its non-voting Series E Convertible Preferred Stock. The public offering price of each share of common stock is $0.50. January 17, 2019